146 related articles for article (PubMed ID: 32395658)
1. An economic analysis of malaria elimination program in Nepal.
Paudel U; Pant KP
Heliyon; 2020 May; 6(5):e03886. PubMed ID: 32395658
[TBL] [Abstract][Full Text] [Related]
2. Malaria elimination transmission and costing in the Asia-Pacific: Developing an investment case.
Shretta R; Silal SP; Celhay OJ; Gran Mercado CE; Kyaw SS; Avancena A; Fox K; Zelman B; Baral R; White LJ; Maude RJ
Wellcome Open Res; 2019; 4():60. PubMed ID: 32025571
[No Abstract] [Full Text] [Related]
3. Estimating the risk of declining funding for malaria in Ghana: the case for continued investment in the malaria response.
Shretta R; Silal SP; Malm K; Mohammed W; Narh J; Piccinini D; Bertram K; Rockwood J; Lynch M
Malar J; 2020 Jun; 19(1):196. PubMed ID: 32487148
[TBL] [Abstract][Full Text] [Related]
4. Investment case for malaria elimination in South Africa: a financing model for resource mobilization to accelerate regional malaria elimination.
Njau J; Silal SP; Kollipara A; Fox K; Balawanth R; Yuen A; White LJ; Moya M; Pillay Y; Moonasar D
Malar J; 2021 Aug; 20(1):344. PubMed ID: 34399767
[TBL] [Abstract][Full Text] [Related]
5. Using donor funding to catalyse investment in malaria prevention in Ghana: an analysis of the potential impact on public and private sector expenditure.
Paintain L; Kpabitey R; Nyanor-Fosu F; Piccinini Black D; Bertram K; Webster J; Goodman C; Lynch M
Malar J; 2022 Jun; 21(1):203. PubMed ID: 35761255
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Willingness to pay for contagious bovine pleuropneumonia vaccination in Narok South District of Kenya.
Kairu-Wanyoike SW; Kaitibie S; Heffernan C; Taylor NM; Gitau GK; Kiara H; McKeever D
Prev Vet Med; 2014 Aug; 115(3-4):130-42. PubMed ID: 24774477
[TBL] [Abstract][Full Text] [Related]
8. Economic analysis of an internet-based depression prevention intervention.
Ruby A; Marko-Holguin M; Fogel J; Van Voorhees BW
J Ment Health Policy Econ; 2013 Sep; 16(3):121-30. PubMed ID: 24327482
[TBL] [Abstract][Full Text] [Related]
9. Quantifying the economic burden of malaria in Nigeria using the willingness to pay approach.
Jimoh A; Sofola O; Petu A; Okorosobo T
Cost Eff Resour Alloc; 2007 May; 5():6. PubMed ID: 17517146
[TBL] [Abstract][Full Text] [Related]
10. The Investment Case for Malaria Elimination in Thailand: A Cost-Benefit Analysis.
Sudathip P; Kongkasuriyachai D; Stelmach R; Bisanzio D; Sine J; Sawang S; Kitchakarn S; Sintasath D; Reithinger R
Am J Trop Med Hyg; 2019 Jun; 100(6):1445-1453. PubMed ID: 30994098
[TBL] [Abstract][Full Text] [Related]
11. Economic effects of dietary salt reduction policies for cardiovascular disease prevention in Japan: a simulation study of hypothetical scenarios.
Ikeda N; Yamashita H; Hattori J; Kato H; Nishi N
Front Nutr; 2023; 10():1227303. PubMed ID: 38024379
[TBL] [Abstract][Full Text] [Related]
12. Willingness to pay and determinants of choice for improved malaria treatment in rural Nepal.
Morey ER; Sharma VR; Mills A
Soc Sci Med; 2003 Jul; 57(1):155-65. PubMed ID: 12753824
[TBL] [Abstract][Full Text] [Related]
13. Comparative cost-benefit analysis of tele-homecare for community-dwelling elderly in Japan: Non-Government versus Government Supported Funding Models.
Akiyama M; Abraham C
Int J Med Inform; 2017 Aug; 104():1-9. PubMed ID: 28599810
[TBL] [Abstract][Full Text] [Related]
14. Impact of Improving Community-Based Access to Malaria Diagnosis and Treatment on Household Costs.
Castellani J; Nsungwa-Sabiiti J; Mihaylova B; Ajayi IO; Siribié M; Afonne C; Balyeku A; Sermé L; Sanou AK; Sombié BS; Tiono AB; Sirima SB; Kabarungi V; Falade CO; Kyaligonza J; Evers SM; Paulus AT; Petzold M; Singlovic J; Gomes M
Clin Infect Dis; 2016 Dec; 63(suppl 5):S256-S263. PubMed ID: 27941102
[TBL] [Abstract][Full Text] [Related]
15. Towards universal health coverage: an example of malaria intervention in Nepal.
Adhikari SR
WHO South East Asia J Public Health; 2014; 3(1):103-112. PubMed ID: 28607264
[TBL] [Abstract][Full Text] [Related]
16. An economic case study of the control of dog-mediated rabies by an animal welfare organisation in Jaipur, India.
Larkins AJ; Reece JF; Shaw APM; Thrusfield MV
Prev Vet Med; 2020 Oct; 183():105120. PubMed ID: 32890917
[TBL] [Abstract][Full Text] [Related]
17. A cost benefit analysis of elimination of kala-azar in Indian subcontinent: an example of Nepal.
Adhikari SR; Supakankunti S
J Vector Borne Dis; 2010 Sep; 47(3):127-39. PubMed ID: 20834081
[TBL] [Abstract][Full Text] [Related]
18. Vaccine preventable diseases surveillance in Nepal: How much does it cost?
Huang XX; Bose AS; Gupta BP; Rai P; Joshi S; Gautam JS; Tinkari BS; Vandelaer J; Cohen AL; Patel MK
Vaccine; 2021 Sep; 39(40):5982-5990. PubMed ID: 34419305
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of long-lasting insecticide-treated hammocks in preventing malaria in South-central Vietnam.
Morel CM; Thang ND; Erhart A; Xa NX; Peeters Grietens K; Xuan Hung L; Thuan le K; Van Ky P; Hung NM; Coosemans M; D'Alessandro U; Mills A
PLoS One; 2013; 8(3):e58205. PubMed ID: 23536790
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
